Novartis Institutes for BioMedical Research, Inc.

Novartis Institutes for BioMedical Research, Inc.
Locations Update This Record Cases by Outcome Cases by Type	SEC CIK 1673852

Add a document

Description
Summary
Document Type	Academic Paper Corporate Document - Internal Corporate Document - Public Court Document Equity Research Government Document - Federal Government Document - State Government Document - Local FBI File Public Records Request Response - FOIA Public Records Request Response - State Non-Profit Report Police Report White Paper
Document Date
Document Source
Source URL
File
	If you would like to be credited for contributing this document, make sure to sign in or sign up first. Once uploaded, your document may not be immediately visible to the public as we review each document for legal issues. Thanks for your patience!

Go Pro to view an analysis and graphs of case roles, types and more.

Filter By From To

	Date Filed	Venue	Case Number	Title	Party Type
	11/9/2017	New Jersey District Court	2:17-cv-11478	EVANS v. NOVARTIS CORPORATION et al	Defendant
	10/3/2017	New Jersey District Court	2:17-cv-07797	MARTIN v. NOVARTIS CORPORATION et al	Defendant
	9/27/2017	New Jersey District Court	2:17-cv-07531	BROOKS v. NOVARTIS CORPORATION et al	Defendant
	9/26/2017	New Jersey District Court	2:17-cv-07494	SNYDER v. NOVARTIS CORPORATION et al	Defendant
	8/8/2017	New Jersey District Court	2:17-cv-05880	9C53B31 et al v. AstraZeneca Pharmaceuticals LP et al	Defendant
	2/8/2017	Illinois Southern District Court	3:17-cv-00131	9C53B31 et al v. AstraZeneca Pharmaceuticals LP et al	Defendant

6 Rows Total

Inside Counsel (5)

Go Pro to view corporate inside counsel.

Outside Counsel (66)

	Last Name	First Name	Middle Name	Firm	Location
				Finnegan, Henderson, Farabow, Garrett & Dunn...	Washington, DC
	Arbor	Ann			ANN ARBOR, MI
	Barnett	Scott	D.		Chicago, IL
	Bofill	Adam		Dentons (US) LLP	Palo Alto, CA
	Bosch	Michele
	Czerwonka	Lori			CAMBRIDGE, MA
	Decamp	James	D.	Clark + Elbing, Llp	Boston, MA
	Decamp	James	D.		Boston, MA
	Decamp	James		Clark + Elbing, Llp	BOSTON, MA
	DEPT/M	PATENT		Cooley LLP	Washington, DC
	Dillon	Susan			CAMBRIDGE, MA
	DOCKETING	IP		Arnold & Porter, LLP	Washington, DC
	Drury	Kathleen	M.		Cambridge, MA
	Drury	Kathleen			Cambridge, MA
	E.	Patent	Dept/mark	Cooley LLP	Washington, DC
	Gupta	Meghana		Fish & Richardson, PC	MINNEAPOLIS, MN
	JACQUIN	ANDREA			East Hanover, NJ
	Johnson	Maria		Novartis Institute For Biomedical Research, ...	Cambridge, MA
	Johnson	Maria	G.	Novartis Pharmaceuticals Corporation	East Hanover, NJ
	Kendall	John	T.	Fish & Richardson, PC	MINNEAPOLIS, MN
	Klein	Stephen	A.
	KLEPACKY	CINDY			EAST HANOVER, NJ
	Lazarow	Mark			East Hanover, NJ
	Lee	Ms.	Doris	Mintz, Levin, Cohn, Ferris, Glovsky & Popeo,...	SAN DIEGO, CA
	Mabry	Diana			CAMBRIDGE, MA
	Marte	Jean			CAMBRIDGE, MA
	Martinez	Gaby			Cambridge, MA
	Mason	Katie			BOSTON, MA
	Mason	Katie		K&L Gates LLP	BOSTON, MA
	Melanson	Tara			CAMBRIDGE, MA
	Melanson	Tara	M.		CAMBRIDGE, MA
	Michaiah	Nibr	Patents		Cambridge, MA
	Moten	Alicia			SAN DIEGO, CA
	Pc	Rimon			Los Angeles, CA
	Place	One	International	Dechert LLP	BOSTON, MA
	Plaza	One	Health	Novartis Pharmaceuticals Corporation	EAST HANOVER, NJ
	Property	Biospark	Intellectual		Cambridge, MA
	Reissaus	Andrew	Lane
	Roberts	Leslie		Lathrop Gpm Llp	BOSTON, MA
	Romanov	Veronica			CAMBRIDGE, MA
	Sapovits	Lisa	R.		WAYNE, PA
	Sapovits	Lisa	R.	Saul Ewing LLP	WAYNE, PA
	Shereda	Robert	D.		ANN ARBOR, MI
	Shereda	Robert	S.		Ann Arbor, MI
	Smith	Amanda			Cambridge, MA
	Smith	Valerie		NOVARTIS INSTITUTES FOR BIOMED. RESEARCH, IN...	CAMBRIDGE, MA
	Street	One	Main	Lando & Anastasi, LLP	CAMBRIDGE, MA
	Street	One	Lincoln	K&L Gates LLP	BOSTON, MA
	Stritenberger	Kelly			EAST HANOVER, NJ
	Sullivan	Bart	C.		St. Louis, MO
	Sussman	Adam	D.	Crowell & Moring LLP	CHICAGO, IL
	Swartwout	Charles	J.
	Talapatra	Sunit		FOLEY & LARDNER LLP	Washington, DC
	TANNER	LORNA		Sheppard Mullin LLP	Palo Alto, CA
	Teigen	Robert	Michael		Madison , WI
	Teigen	Robert	M.		Madison , WI
	Trinque	Brian	C.
	Trinque	Brian	C.	Lathrop Gpm Llp
	Wang	Zhongyu		McCarter & English LLP	BOSTON, MA
	Watson	Safiya			CAMBRIDGE, MA
	Weller	Maddie	M.		Atlanta, GA
	West	Centre	Square	Saul Ewing Arnstein & Lehr LLP	Philadelphia, PA
	West	Centre	Square	Lisa Sapovits, Saul Ewing Arnstein & Lehr Ll...	Philadelphia, PA
	Whittaker	Michael	A.	Acuity Law Group, P.C.	San Diego, CA
	Wigger	Benjamin		Dentons (US) LLP	Palo Alto, CA
	Wigley	David	E.		ATLANTIC, GA

66 Rows Total

Filter By Form All Records 3 4 5 SC 13D SC 13D/A SC 13G From To

	Date	Entity	Form Number	Description
	2/8/2023		SC 13G
	10/31/2022		SC 13G/A
	8/31/2022		SC 13G/A
	2/8/2021		SC 13G/A
	2/5/2021		SC 13G
	1/22/2021		SC 13D/A
	8/20/2020		SC 13D/A
	6/15/2020		SC 13G
	3/30/2020		SC 13D/A
	3/10/2020		SC 13G/A
	2/14/2019		5	Annual statement of changes in beneficial ownership of securitie...
	2/4/2019		SC 13G
	4/23/2018		SC 13G
	4/23/2018		4	Statement of changes in beneficial ownership of securities
	4/18/2018		3	Initial statement of beneficial ownership of securities
	4/4/2018		4	Statement of changes in beneficial ownership of securities
	3/27/2018		3	Initial statement of beneficial ownership of securities
	3/23/2018		SC 13D/A
	3/23/2018		3	Initial statement of beneficial ownership of securities
	12/14/2017		SC 13D/A
	12/14/2017		4	Statement of changes in beneficial ownership of securities
	3/7/2017	Novartis AG	4	Statement of changes in beneficial ownership of securities
	5/11/2016		SC 13D
	5/11/2016	Novartis AG	4	Statement of changes in beneficial ownership of securities
	5/5/2016	Novartis AG	3	Initial statement of beneficial ownership of securities

25 Rows Total

	Date Recorded	Party	Role	Document Type	Document No.	Invention Title
	4/18/2025	Novartis Ag	Assignee	Application Publication	18434265 20240317840	Hepatitis B Antibodies Hepatitis B Antibodies
	4/18/2025	Holdorf, Meghan Marie	Assignor	Application Publication	18434265 20240317840	Hepatitis B Antibodies Hepatitis B Antibodies
	3/26/2025	Novartis Ag	Assignee	Application Publication	18937914 20250064964	Antibody Drug Conjugates For Ablating Hematopoietic Stem Cells Antibody Drug Conjugates For Ablating Hematopoietic Stem Cells
	3/26/2025	Burger, Matthew T.	Assignor	Application Publication	18937914 20250064964	Antibody Drug Conjugates For Ablating Hematopoietic Stem Cells Antibody Drug Conjugates For Ablating Hematopoietic Stem Cells
	3/26/2025	Lee-hoeflich, Si Tuen	Assignor	Application Publication	18937914 20250064964	Antibody Drug Conjugates For Ablating Hematopoietic Stem Cells Antibody Drug Conjugates For Ablating Hematopoietic Stem Cells
	3/10/2025	Novartis Ag	Assignee	Application Application Publication Publication	16759251 16759251 20200370012 20200370012
	3/10/2025	Orlando, Elena	Assignor	Application Application Publication Publication	16759251 16759251 20200370012 20200370012
	2/24/2025	Novartis Ag	Assignee	Application Publication	17271430 20220364055
	2/24/2025	Stein, Andrew	Assignor	Application Publication	17271430 20220364055
	2/24/2025	Price, Andrew	Assignor	Application Publication	17271430 20220364055
	2/24/2025	Blankenship, John	Assignor	Application Publication	17271430 20220364055
	2/24/2025	Dranoff, Glenn	Assignor	Application Publication	17271430 20220364055
	2/24/2025	Fleming, Tony	Assignor	Application Publication	17271430 20220364055
	2/24/2025	Zhu, Xu	Assignor	Application Publication	17271430 20220364055
	2/24/2025	Abujoub, Aida	Assignor	Application Publication	17271430 20220364055
	2/24/2025	Zhang, Chonghui	Assignor	Application Publication	17271430 20220364055
	2/24/2025	Lim, Hyungwook	Assignor	Application Publication	17271430 20220364055
	2/24/2025	Huang, Lu	Assignor	Application Publication	17271430 20220364055
	2/24/2025	Brogdon, Jennifer	Assignor	Application Publication	17271430 20220364055
	2/24/2025	Engels, Boris	Assignor	Application Publication	17271430 20220364055
	2/24/2025	Greene, Michael R.	Assignor	Application Publication	17271430 20220364055
	2/24/2025	Holmberg, Brian	Assignor	Application Publication	17271430 20220364055
	2/24/2025	Hong, Connie	Assignor	Application Publication	17271430 20220364055
	2/24/2025	Bu, Dexiu	Assignor	Application Publication	17271430 20220364055
	2/24/2025	Kodrasi, Olja	Assignor	Application Publication	17271430 20220364055
	2/24/2025	Sohoni, Akash	Assignor	Application Publication	17271430 20220364055
	2/24/2025	Treanor, Louise	Assignor	Application Publication	17271430 20220364055
	2/21/2025	Park, Hye-yeon	Assignor	Application Publication	18422517 20250002499
	2/21/2025	Neef, James	Assignor	Application Publication	18422517 20250002499
	2/21/2025	Zhou, Xilin	Assignor	Application Publication	18422517 20250002499
	2/21/2025	Kim, Sung David C.	Assignor	Application Publication	18422517 20250002499
	2/21/2025	Sadaghiani, Amir Masoud	Assignor	Application Publication	18422517 20250002499
	2/21/2025	Lubicka, Danuta	Assignor	Application Publication	18422517 20250002499
	2/21/2025	Pathak, Tejaskumar Pankajbhai	Assignor	Application Publication	18422517 20250002499
	2/21/2025	Dranoff, Glenn	Assignor	Application Publication	18392954 20240343808
	2/21/2025	Novartis Ag	Assignee	Application Publication	18392954 20240343808
	2/21/2025	Novartis Ag	Assignee	Application Publication	18422517 20250002499
	2/7/2025	Zou, Bin	Assignor	Application Publication	18657123 20240352030	N-substituted Tetrahydrothienopyridine Derivatives And Uses Thereof N-substituted Tetrahydrothienopyridine Derivatives And Uses Thereof
	2/7/2025	Simon, Oliver	Assignor	Application Publication	18657123 20240352030	N-substituted Tetrahydrothienopyridine Derivatives And Uses Thereof N-substituted Tetrahydrothienopyridine Derivatives And Uses Thereof
	2/7/2025	Yeung, Bryan Ks	Assignor	Application Publication	18657123 20240352030	N-substituted Tetrahydrothienopyridine Derivatives And Uses Thereof N-substituted Tetrahydrothienopyridine Derivatives And Uses Thereof
	2/7/2025	Yokokawa, Fumiaki	Assignor	Application Publication	18657123 20240352030	N-substituted Tetrahydrothienopyridine Derivatives And Uses Thereof N-substituted Tetrahydrothienopyridine Derivatives And Uses Thereof
	2/7/2025	Sim, Wei Lin Sandra	Assignor	Application Publication	18657123 20240352030	N-substituted Tetrahydrothienopyridine Derivatives And Uses Thereof N-substituted Tetrahydrothienopyridine Derivatives And Uses Thereof
	2/7/2025	Kounde, Cyrille	Assignor	Application Publication	18657123 20240352030	N-substituted Tetrahydrothienopyridine Derivatives And Uses Thereof N-substituted Tetrahydrothienopyridine Derivatives And Uses Thereof
	2/7/2025	Yeo, Hui Quan	Assignor	Application Publication	18657123 20240352030	N-substituted Tetrahydrothienopyridine Derivatives And Uses Thereof N-substituted Tetrahydrothienopyridine Derivatives And Uses Thereof
	2/7/2025	Wang, Gang Quan	Assignor	Application Publication	18657123 20240352030	N-substituted Tetrahydrothienopyridine Derivatives And Uses Thereof N-substituted Tetrahydrothienopyridine Derivatives And Uses Thereof
	2/7/2025	Novartis Ag	Assignee	Application Publication	18657123 20240352030
	2/3/2025	Novartis Ag	Assignee	Application Publication	18924066 20250092042	Heteroaryl Substituted Spiropiperidinyl Derivatives And Pharmaceutical U... Heteroaryl Substituted Spiropiperidinyl Derivatives And Pharmaceutical U...
	2/3/2025	Aurigene Pharmaceutical Services Ltd.	Assignor	Application Publication	18924066 20250092042	Heteroaryl Substituted Spiropiperidinyl Derivatives And Pharmaceutical U... Heteroaryl Substituted Spiropiperidinyl Derivatives And Pharmaceutical U...
	2/3/2025	Chen, Xin	Assignor	Application Publication	18924066 20250092042	Heteroaryl Substituted Spiropiperidinyl Derivatives And Pharmaceutical U... Heteroaryl Substituted Spiropiperidinyl Derivatives And Pharmaceutical U...
	2/3/2025	Sandham, David Andrew	Assignor	Application Publication	18924066 20250092042	Heteroaryl Substituted Spiropiperidinyl Derivatives And Pharmaceutical U... Heteroaryl Substituted Spiropiperidinyl Derivatives And Pharmaceutical U...
	2/3/2025	Cheung, Atwood Kim	Assignor	Application Publication	18924066 20250092042	Heteroaryl Substituted Spiropiperidinyl Derivatives And Pharmaceutical U... Heteroaryl Substituted Spiropiperidinyl Derivatives And Pharmaceutical U...
	2/3/2025	Hurley, Timothy Brian	Assignor	Application Publication	18924066 20250092042	Heteroaryl Substituted Spiropiperidinyl Derivatives And Pharmaceutical U... Heteroaryl Substituted Spiropiperidinyl Derivatives And Pharmaceutical U...
	2/3/2025	Tichkule, Ritesh Bhanudasji	Assignor	Application Publication	18924066 20250092042	Heteroaryl Substituted Spiropiperidinyl Derivatives And Pharmaceutical U... Heteroaryl Substituted Spiropiperidinyl Derivatives And Pharmaceutical U...
	2/3/2025	Labbe-giguere, Nancy	Assignor	Application Publication	18924066 20250092042	Heteroaryl Substituted Spiropiperidinyl Derivatives And Pharmaceutical U... Heteroaryl Substituted Spiropiperidinyl Derivatives And Pharmaceutical U...
	2/3/2025	Patel, Tajesh	Assignor	Application Publication	18924066 20250092042	Heteroaryl Substituted Spiropiperidinyl Derivatives And Pharmaceutical U... Heteroaryl Substituted Spiropiperidinyl Derivatives And Pharmaceutical U...
	1/23/2025	Novartis Ag	Assignee	Application Publication	18729542 20250099465
	1/23/2025	Novartis Ag	Assignee	Application Publication	18729542 20250099465
	1/23/2025	Bhattacharya, Souvik	Assignor	Application Publication	18729542 20250099465	Remibrutinib For Use In The Treatment Of Hidradenitis Suppurativa Remibrutinib For Use In The Treatment Of Hidradenitis Suppurativa
	1/23/2025	Bhattacharya, Souvik	Assignor	Application Publication	18729542 20250099465	Remibrutinib For Use In The Treatment Of Hidradenitis Suppurativa Remibrutinib For Use In The Treatment Of Hidradenitis Suppurativa
	1/16/2025	Novartis Ag	Assignee	Application Publication	18715832 20250032488	Methods Of Treatment Using Lou064 Methods Of Treatment Using Lou064
	1/16/2025	Bhattacharya, Souvik	Assignor	Application Publication	18715832 20250032488	Methods Of Treatment Using Lou064 Methods Of Treatment Using Lou064
	1/16/2025	Novartis Ag	Assignee	Application Publication	18715832 20250032488	Methods Of Treatment Using Lou064 Methods Of Treatment Using Lou064
	1/16/2025	Bhattacharya, Souvik	Assignor	Application Publication	18715832 20250032488	Methods Of Treatment Using Lou064 Methods Of Treatment Using Lou064
	1/15/2025	Bhattacharya, Souvik	Assignor	Application Publication	18715832 20250032488	Methods Of Treatment Using Lou064 Methods Of Treatment Using Lou064
	1/15/2025	Bhattacharya, Souvik	Assignor	Application Publication	18715832 20250032488	Methods Of Treatment Using Lou064 Methods Of Treatment Using Lou064
	1/15/2025	Novartis Ag	Assignee	Application Publication	18715832 20250032488	Methods Of Treatment Using Lou064 Methods Of Treatment Using Lou064
	1/15/2025	Novartis Ag	Assignee	Application Publication	18715832 20250032488	Methods Of Treatment Using Lou064 Methods Of Treatment Using Lou064
	1/10/2025	Mckenna, Jeffrey	Assignor	Application Publication	18904492 20250120982	Covalent Targeting Of E3 Ligases Covalent Targeting Of E3 Ligases
	1/10/2025	Tallarico, John A.	Assignor	Application Publication	18904492 20250120982	Covalent Targeting Of E3 Ligases Covalent Targeting Of E3 Ligases
	1/10/2025	Schirle, Markus	Assignor	Application Publication	18904492 20250120982	Covalent Targeting Of E3 Ligases Covalent Targeting Of E3 Ligases
	1/10/2025	Novartis Ag	Assignee	Application Publication	18904492 20250120982
	12/19/2024	Zhang, Chun	Assignor	Application Publication Patent	15626981 20180009795 10093663	Piperidinyl-Indole Derivatives Complement Factor B Inhibitors and Uses T... Piperidinyl-Indole Derivatives Complement Factor B Inhibitors and Uses T... Piperidinyl-Indole Derivatives Complement Factor B Inhibitors and Uses T...
	12/19/2024	Ehara, Takeru	Assignor	Application Publication Patent	15626981 20180009795 10093663	Piperidinyl-Indole Derivatives Complement Factor B Inhibitors and Uses T... Piperidinyl-Indole Derivatives Complement Factor B Inhibitors and Uses T... Piperidinyl-Indole Derivatives Complement Factor B Inhibitors and Uses T...
	12/19/2024	Adams, Christopher Michael	Assignor	Application Publication Patent	15626981 20180009795 10093663	Piperidinyl-Indole Derivatives Complement Factor B Inhibitors and Uses T... Piperidinyl-Indole Derivatives Complement Factor B Inhibitors and Uses T... Piperidinyl-Indole Derivatives Complement Factor B Inhibitors and Uses T...
	12/19/2024	Karki, Rajeshri Ganesh	Assignor	Application Publication Patent	15626981 20180009795 10093663	Piperidinyl-Indole Derivatives Complement Factor B Inhibitors and Uses T... Piperidinyl-Indole Derivatives Complement Factor B Inhibitors and Uses T... Piperidinyl-Indole Derivatives Complement Factor B Inhibitors and Uses T...
	12/19/2024	Capparelli, Michael Paul	Assignor	Application Publication Patent	15626981 20180009795 10093663	Piperidinyl-Indole Derivatives Complement Factor B Inhibitors and Uses T... Piperidinyl-Indole Derivatives Complement Factor B Inhibitors and Uses T... Piperidinyl-Indole Derivatives Complement Factor B Inhibitors and Uses T...
	12/19/2024	Mainolfi, Nello	Assignor	Application Publication Patent	15626981 20180009795 10093663	Piperidinyl-Indole Derivatives Complement Factor B Inhibitors and Uses T... Piperidinyl-Indole Derivatives Complement Factor B Inhibitors and Uses T... Piperidinyl-Indole Derivatives Complement Factor B Inhibitors and Uses T...
	12/19/2024	Novartis Ag	Assignee	Application Publication Application	15626981 20180009795 10093663
	12/19/2024	Koch, Alexander Wolfgang	Assignor	Application Publication	18655058 20250101130	Factor Xi Antibodies And Methods Of Use Factor Xi Antibodies And Methods Of Use
	12/19/2024	Novartis Ag	Assignee	Application Publication	18655058 20250101130
	12/9/2024	Sethuraman, Vijay	Assignor	Application Publication	18795371 20240391938	Crystalline Forms Of A Tlr7/tlr8 Inhibitor Crystalline Forms Of A Tlr7/tlr8 Inhibitor
	12/9/2024	Novartis Ag	Assignee	Application Publication	18795371 20240391938	Crystalline Forms Of A Tlr7/tlr8 Inhibitor Crystalline Forms Of A Tlr7/tlr8 Inhibitor
	11/20/2024	Singh, Reshma	Assignor	Application Publication	17811606 20230000964	Mesothelin Chimeric Antigen Receptor (car) And Antibody Against Pd-l1 In... Mesothelin Chimeric Antigen Receptor (car) And Antibody Against Pd-l1 In...
	11/20/2024	Novartis Ag	Assignee	Application Publication	17811606 20230000964	Mesothelin Chimeric Antigen Receptor (car) And Antibody Against Pd-l1 In... Mesothelin Chimeric Antigen Receptor (car) And Antibody Against Pd-l1 In...
	11/20/2024	Singh, Reshma	Assignor	Application Publication Patent	17811606 20230000964 12186278	Mesothelin Chimeric Antigen Receptor (car) And Antibody Against Pd-l1 In... Mesothelin Chimeric Antigen Receptor (car) And Antibody Against Pd-l1 In... Mesothelin Chimeric Antigen Receptor (car) And Antibody Against Pd-l1 In...
	11/20/2024	Novartis Ag	Assignee	Application Publication Patent	17811606 20230000964 12186278	Mesothelin Chimeric Antigen Receptor (car) And Antibody Against Pd-l1 In... Mesothelin Chimeric Antigen Receptor (car) And Antibody Against Pd-l1 In... Mesothelin Chimeric Antigen Receptor (car) And Antibody Against Pd-l1 In...
	11/19/2024	Brogdon, Jennifer	Assignor	Application Publication Application	17811606 20230000964 12186278	Mesothelin Chimeric Antigen Receptor (car) And Antibody Against Pd-l1 In... Mesothelin Chimeric Antigen Receptor (car) And Antibody Against Pd-l1 In...
	11/19/2024	Engels, Boris	Assignor	Application Publication Patent	17811606 20230000964 12186278	Mesothelin Chimeric Antigen Receptor (car) And Antibody Against Pd-l1 In... Mesothelin Chimeric Antigen Receptor (car) And Antibody Against Pd-l1 In... Mesothelin Chimeric Antigen Receptor (car) And Antibody Against Pd-l1 In...
	11/11/2024	Novartis Ag	Assignee	Application Publication	17605859 20220251152	Compositions And Methods For Selective Protein Degradation Compositions And Methods For Selective Protein Degradation
	11/11/2024	Novartis Ag	Assignee	Application Publication	17605859 20220251152
	11/11/2024	Renaud, Nicole	Assignor	Application Publication	17605859 20220251152
	11/11/2024	Golosov, Andrei	Assignor	Application Publication	17605859 20220251152
	11/11/2024	Hild, Marc Horst Peter	Assignor	Application Publication	17605859 20220251152
	11/11/2024	Carbonneau, Seth	Assignor	Application Publication	17605859 20220251152
	11/6/2024	Novartis Ag	Assignee	Application Publication	18826887 20250002479	Pyrazolopyridine Derivatives And Uses Thereof Pyrazolopyridine Derivatives And Uses Thereof
	11/6/2024	Novartis Ag	Assignee	Application Publication Patent	18826887 20250002479 12252482	Pyrazolopyridine Derivatives And Uses Thereof Pyrazolopyridine Derivatives And Uses Thereof Pyrazolopyridine Derivatives And Uses Thereof

96 Rows Total

Novartis Institutes for BioMedical Research, Inc. has not been involved in any trademark assignment transactions in the PlainSite database.

Parent Entities

• Homology Medicines, Inc.
• Intellia Therapeutics, Inc.
• Novartis AG
• Surface Oncology, Inc.

Corporate Family (4)

Track Corporate Family

• Homology Medicines, Inc., None
• Intellia Therapeutics, Inc., None
• Novartis AG, None
• Surface Oncology, Inc., None

Subsidiaries

• Novartis AG

Sign in to add additional links.

Incoming Payments

This organization has not disclosed any incoming payments from lobbying groups.

Outgoing Payments

This organization has not disclosed any outgoing payments to lobbying groups.